Table 1.
| JC 2009 | IDF (2005) | NCEP ATP III 2004 | NCEP ATP III (2001) | EGIR 1999 | WHO 1998 | |
|---|---|---|---|---|---|---|
| Number of criteria | Three or more of: | And two or more of †: | Three or more of: | Three or more of: | And two or more of †: | And two or more of †: |
| Obesity | Population- and country-specific definitions * | WC ≥ 94 cm men, WC ≥ 80 cm women | WC ≥ 102 cm (men), WC ≥ 88 cm (women) | WC ≥ 102 cm (men), WC ≥ 88 cm (women) | WC ≥ 94 cm (men, WC ≥ 80 cm (women) | BMI > 30 and/or WHR > 0.9 (men), WHR > 0.85 (women) |
| Blood Pressure mmhg | ≥ 130/85 or treatmen | ≥130/≥85 or treatment | ≥ 130/85 or treatment | ≥ 130/85 or treatment | ≥ 140/90 | ≥ 140/90 |
| Dyslipidaemia:HDL-C | ≥ 40 mg/dL (1.03 mol/L) in men, ≥ 50 mg/dL (1.29 mmol/L) in women, or treatment | ≥ 40 mg/dL (1.03 mol/L) in men, ≥ 50 mg/dL (1.29 mmol/L) in women, or treatment | ≥ 40 mg/dL (1.03 mol/L) in men, ≥ 50 mg/dL (1.29 mmol/L) in women, or treatment | ≥ 40 mg/dL (1.03 mmol/L) in men or ≥ 50 mg/dL (1.29 mmol/L) in women | ≥ 39 mg/dL (1.0 mmol/L) or treatment | ≥ 35 mg/dL (0.9 mmol/L) in men or ≥ 39 mg/dL (≥ 1.0 mmol/L) in women |
| Triglycerides | ≥150 mg/dL (1.7 mmol/L) or treatment | ≥150 mg/dL (1.7 mmol/L) or treatment | ≥150 mg/dL (1.7 mmol/L) or treatment | ≥150 mg/dL (1.7 mmol/L) | ≥150 mg/dL (1.7 mmol/L) | ≥178 mg/dL (2.0 mmol/L) or treatment |
| Glucose intolerance or fasting plasma glucose | ≥100 mg/dL (5.6 mmol/L) or T2D | ≥100 mg/dL (5.6 mmol/L) or T2D | ≥100 mg/dL (5.6 mmol/L) or T2D | ≥110 mg/dL (6.1 mmol/L) | ≥110 mg/dL (6.1 mmol/L) | ≥110 mg/dL (6.1 mmol/l), DM, IGT, IR |
* cut-off values differ according to ethnic origin , for Mediterranean and sub Saharian people, the threshold of obesity defined by WC corres pond to the IDF definition;
BMI = body mass index; JC= Joint Consensus; DM = diabetes mellitus; EGIR = European Group against Insulin Resistance; HDL-C = high-density lipoproteincholesterol; IDF = International Diabetes Federation; IGT = impaired glucose tolerance; IR = insulin resistance;NCEP ATPIII = National Cholesterol Education Programme Adult Treatment Panel; T2 D, type II diabetes mellitus; WC = waist circumference; WHO = World Health Organization; WHR = waist hip ratio.
†For IDF 2005, EGIR 1999 and WHO 1998. The definition of metabolic syndrome focus on the presence of diabetes, glucose intolerance or insulin resistance together with the presence of at least two other components from a list of five components.